Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × gusacitinib × Dermatologic × Clear all

Phase

Status

Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 1 Basal Cell Nevus Syndrome 1

Interventions

pembrolizumab 2 talimogene laherparepvec 1 sargramostim 1 romiplostim 1 imisopasem manganese 1 gusacitinib 1 dabrafenib 1 cobimetinib 1 Propranolol 1 Paclitaxel 1 ON 01910 1 Microscopy, Confocal 1 Magnetic Resonance Spectroscopy 1 Drug Therapy 1 Curettage 1 CA-4948 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03208296 2023-02-06

Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

Ascend Biopharmaceuticals Ltd

Phase 1/2 Suspended

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡